Repurposing BCG and MMR Vaccines for Combating COVID-19: A Review and Opinion Based on Clinical Evidence
Our review comprehends past and recent developments encircling the two vaccines, BCG and MMR, which have efficacy lasting 10 years and are known to trigger the production of Interferon and various cytokines. BCG has depicted long-lasting effects, reduction in mortality, and hospitalizations associat...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/83161 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Repurposing BCG and MMR Vaccines for Combating COVID-19: A Review and Opinion Based on Clinical Evidence
- Repurposing Infectious Pathogen Vaccines in Cancer Immunotherapy
- Artritis reactiva por BCG intravesical
- Immunotherapy of Urinary Bladder Carcinoma: BCG and Beyond
- Sci-MMR: Benchmarking Multi-Step Evidence-Grounded Scientific Reasoning in Multimodal Agents
- Epimutation in DNA Mismatch Repair (MMR) Genes
- ChatBCG: Can AI Read Your Slide Deck?